Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, 200233, China
Location status: Recruiting
NCT Number: NCT07168122
The goal of this observational study is to establish the normal reference intervals of salivary cortisol and optimal cut-offs for Cushing's sydrome and adrenal insufficiency.
Interested in participating?
Request Info18 year–80 year
All sexes
Observational
Shanghai, Shanghai Municipality, 200233, China
Location status: Recruiting
Saliva testing is a non-invasive alternative to blood tests for measuring cortisol, a key hormone for assessing endocrine status and diagnosing conditions like Cushing's syndrome. It accurately reflects physiologically active free cortisol. However, its clinical use is hampered by extremely low cortisol concentrations and the lack of reliable detection methods. We have developed two advanced technologies: an immunomagnetic-bead-based LC-MS assay with simplified preparation, and a fluorescence immunoassay system for point-of-care testing. To promote their clinical adoption, this study will establish normal reference intervals of salivary cortisol for both methods in a healthy population and optimal cut-offs in cases of Cushing's sydrome and adrenal insufficiency.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Healthy Volunteers:
Inclusion criteria
Exclusion criteria
Cases:
Inclusion criteria
Exclusion criteria
Time frame: 8:00, 16:00 and 23:00 on the day of sample collection
Salivary cortisol levels were evaluated by immunomagnetic-bead-based LC-MS assay and fluorescence immunoassay system to establish its reference intervals according to the 2.5th and 97.5th percentiles.
Time frame: 23:00 on the day of sample collection
The diagnostic cut-off for each analysis method was defined as either the calculated upper reference interval (97.5th percentile) or the optimal value determined by the Youden index. The sensitivity, specificity and area under curve for Cushing's syndrome was calculated using samples from all available healthy controls and cases.
Time frame: 8:00 on the day of sample collection
The diagnostic cut-off for each analysis method was defined as either the calculated lower reference intervals (2.5th percentile) or the optimal value determined by the Youden index. The sensitivity, specificity and area under curve for adrenal insufficiency was calculated using samples from all available healthy controls and cases.
Time frame: 8:00 or 23:00 on the day of sample collection
The diagnostic accuracies of the fluorescence immunoassay system and the immunomagnetic-bead-based LC-MS assay were compared by analyzing their areas under the receiver operating characteristic (ROC) curves using DeLong's test for paired statistics.
Time frame: 8:00, 16:00 and 23:00 on the day of sample collection
To assess the agreement in assessment of salivary cortisol between immunomagnetic-bead-based LC-MS assay and fluorescence immunoassay system
Time frame: 8:00, 16:00 and 23:00 on the day of sample collection
Comparsion of salivary cortisol levels in subgroups of age
Time frame: 8:00, 16:00 and 23:00 on the day of sample collection
Comparsion of salivary cortisol levels in subgroups of sex
Time frame: 8:00, 16:00 and 23:00 on the day of sample collection
Comparsion of salivary cortisol levels in subgroups of body mass index
Contact information is provided by the study sponsor or research team.
Shanghai 6th People's Hospital
Other
Study for Reference Intervals and Optimal Cut-offs for Salivary Cortisol
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07726537
Healthy Adult
Graz, Styria, Austria
View Trial DetailsNCT07361406
Healthy Adult
Wageningen, Gelderland, Netherlands
View Trial DetailsNCT07649161
Healthy Adult
Boston, Massachusetts, United States
View Trial DetailsNCT07527247
Healthy Adult, Immune System Responses and Trained Immunity After AS01 Administration
Singapore
View Trial Details